Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Computerized Program for Brachytherapy

By HospiMedica staff writers
Posted on 09 Mar 2001
A new computerized system helps radiation oncologists optimize the placement of radioactive seeds. More...
The system targets escalated doses of radiation at tumor pockets and accounts for changes that occur in prostate volume during treatment.

Other benefits of the system include a dramatic reduction in the time required to design the radioactive seed treatment, allowing plans to be created in minutes and revised as the treatment proceeds. Ultrasound images of the patient's prostate are used by the system to help determine optimal radioactive seed placement based on prostate volume, location of tumor pockets, radioactivity levels of the seeds, location of the urethra, and regions of the prostate that may be unreachable by placement needles. The system operates on a wide range of computing platforms, including Windows NT PCs.

The system includes a dose-calculation engine, a modeling module, an optimization engine, and a graphical evaluation tool. It was developed by Eva K. Lee, assistant professor of industrial and systems engineering at the Georgia Institute of Technology and of radiation oncology at Emory University School of Medicine (both in Atlanta, GA, USA). Lee collaborated on the work with Dr. Marco Zaider, professor and head of brachytherapy physics at Memorial Sloan Kettering Cancer Center (NY, NY, USA).

"We can deliver better precision and create the optimal plan for each patient,” says Lee. "This system should help cut the recurrence rate for prostate cancer and reduce toxicity to healthy tissue.” Lee thinks that manipulating the large number of variables involved in brachytherapy is far too complex for even the best human experts. She has used patient data to compare her system with treatment plans designed by radiation oncologists and the results suggest the system will provide significant improvements in treatment outcomes.



Related Links:
Georgia Institute of Technology

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.